Monday, 21 May 2018

Nabriva's pneumonia drug succeeds in late-stage study

(Reuters) - Nabriva Therapeutics Plc said on Monday its drug to treat adults suffering from a type of pneumonia met the main goal of a late-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)